<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=143192"><dc:title>An analysis of the benefits of corporate social responsibility in the pharmaceutical industry</dc:title><dc:creator>Havolli,	Mirlinda	(Avtor)
	</dc:creator><dc:creator>Aleksić,	Darija	(Mentor)
	</dc:creator><dc:subject>pharmaceutical industry</dc:subject><dc:subject>social responsibility</dc:subject><dc:subject>business ethics</dc:subject><dc:subject>reports</dc:subject><dc:subject>intelectual property</dc:subject><dc:subject>costs</dc:subject><dc:subject>value</dc:subject><dc:subject>analysis</dc:subject><dc:subject>cases</dc:subject><dc:subject>Covid-19</dc:subject><dc:publisher>[M. Havolli]</dc:publisher><dc:date>2022</dc:date><dc:date>2022-12-08 04:16:20</dc:date><dc:type>Magistrsko delo/naloga</dc:type><dc:identifier>143192</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>